Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.880
+0.040 (2.17%)
At close: May 22, 2025, 4:00 PM
1.948
+0.068 (3.59%)
After-hours: May 22, 2025, 7:32 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.04 million as of May 22, 2025. Its market cap has decreased by -28.91% in one year.
Market Cap
1.04M
Enterprise Value
-1.89M
1-Year Change
-28.91%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.04M, a decrease of -98.46%. That is a compound annual growth rate of -69.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 1.02M | -61.07% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.81B |
| Johnson & Johnson | 368.56B |
| AbbVie | 321.13B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 274.85B |
| Abbott Laboratories | 231.49B |
| Novartis AG | 222.59B |
| AstraZeneca | 218.71B |